Literature DB >> 29683114

Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer.

Catherine M Bender1, John D Merriman1, Susan M Sereika2, Amanda L Gentry3, Frances E Casillo4, Theresa A Koleck5, Margaret Q Rosenzweig1, Adam M Brufsky6, Priscilla McAuliffe1, Yehui Zhu1, Yvette P Conley1.   

Abstract

OBJECTIVES: This study identified women with unique trajectories of executive function, concentration, and visual working memory before and during adjuvant therapy for breast cancer, and examined phenotypic and genotypic predictors associated with subgroups. SAMPLE &
SETTING: 399 postmenopausal women, of whom 288 were women with early-stage breast cancer and 111 were women without breast cancer, matched on age and years of education to the women with breast cancer, and all at an urban cancer center. METHODS & VARIABLES: A repeated-measures design was used; assessments occurred before adjuvant therapy and every six months post-therapy initiation. Group-based trajectory modeling determined subgroups. Multinomial logistic regression identified phenotypic and genotypic characteristics.
RESULTS: Three executive function and concentration trajectory subgroups were identified. IMPLICATIONS FOR NURSING: Advancing age, greater pretherapy fatigue, and poorer pretherapy cognitive function are associated with the low subgroups. DNA repair and oxidative stress mechanisms may be involved in the cognitive changes that women experience.

Entities:  

Keywords:  aromatase inhibitor; breast cancer; cognitive function; genotypic; phenotypic

Mesh:

Substances:

Year:  2018        PMID: 29683114      PMCID: PMC6052441          DOI: 10.1188/18.ONF.308-326

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  61 in total

1.  Patterns of change in cognitive function with anastrozole therapy.

Authors:  Catherine M Bender; John D Merriman; Amanda L Gentry; Gretchen M Ahrendt; Sarah L Berga; Adam M Brufsky; Frances E Casillo; Meredith M Dailey; Kirk I Erickson; Frances M Kratofil; Priscilla F McAuliffe; Margaret Q Rosenzweig; Christopher M Ryan; Susan M Sereika
Journal:  Cancer       Date:  2015-04-23       Impact factor: 6.860

2.  Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Authors:  Maggie C U Cheang; Miguel Martin; Torsten O Nielsen; Aleix Prat; David Voduc; Alvaro Rodriguez-Lescure; Amparo Ruiz; Stephen Chia; Lois Shepherd; Manuel Ruiz-Borrego; Lourdes Calvo; Emilio Alba; Eva Carrasco; Rosalia Caballero; Dongsheng Tu; Kathleen I Pritchard; Mark N Levine; Vivien H Bramwell; Joel Parker; Philip S Bernard; Matthew J Ellis; Charles M Perou; Angelo Di Leo; Lisa A Carey
Journal:  Oncologist       Date:  2015-04-23

3.  Accelerated aging in the tumor microenvironment: connecting aging, inflammation and cancer metabolism with personalized medicine.

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Stephanos Pavlides; Diana Whitaker-Menezes; Richard G Pestell; Anthony Howell; Federica Sotgia
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

5.  Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.

Authors:  Theresa A Koleck; Catherine M Bender; Susan M Sereika; Gretchen Ahrendt; Rachel C Jankowitz; Kandace P McGuire; Christopher M Ryan; Yvette P Conley
Journal:  Oncol Nurs Forum       Date:  2014-11-01       Impact factor: 2.172

Review 6.  Steroid hormone receptors in breast cancer management.

Authors:  C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1998       Impact factor: 4.872

7.  'Chemobrain' in breast carcinoma?: a prologue.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard Theriault; Aman U Buzdar; Scott Cruickshank; Christina A Meyers
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

8.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

9.  Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Authors:  Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Yuelin Li; Charlotte T Furstenberg; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

10.  Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing.

Authors:  Claudia Bartels; Martin Wegrzyn; Anne Wiedl; Verena Ackermann; Hannelore Ehrenreich
Journal:  BMC Neurosci       Date:  2010-09-16       Impact factor: 3.288

View more
  9 in total

1.  Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer.

Authors:  Maura K McCall; Susan M Sereika; Stephanie Snader; Alexa Lavanchy; Margaret Q Rosenzweig; Yvette P Conley; Jan H Beumer; Catherine M Bender
Journal:  Support Care Cancer       Date:  2022-09-10       Impact factor: 3.359

Review 2.  Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review.

Authors:  Lucy R Haggstrom; Janette L Vardy; Emma-Kate Carson; Davendra Segara; Elgene Lim; Belinda E Kiely
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

3.  Changes in Attentional Function in Patients From Before Through 12 Months After Breast Cancer Surgery.

Authors:  Carmen Kohler; Ming Chang; Yu-Yin Allemann-Su; Marcus Vetter; Miyeon Jung; Misook Jung; Yvette Conley; Steven Paul; Kord M Kober; Bruce A Cooper; Betty Smoot; Jon D Levine; Christine Miaskowski; Maria C Katapodi
Journal:  J Pain Symptom Manage       Date:  2020-01-15       Impact factor: 3.612

Review 4.  The Influence of Physical Activity and Epigenomics On Cognitive Function and Brain Health in Breast Cancer.

Authors:  Monica A Wagner; Kirk I Erickson; Catherine M Bender; Yvette P Conley
Journal:  Front Aging Neurosci       Date:  2020-05-08       Impact factor: 5.750

Review 5.  A narrative review of risk factors and interventions for cancer-related cognitive impairment.

Authors:  Lu Bai; Enyan Yu
Journal:  Ann Transl Med       Date:  2021-01

Review 6.  Symptom trajectories in patients with breast cancer: An integrative review.

Authors:  Tingting Cai; Yueshi Huang; Qingmei Huang; Haozhi Xia; Changrong Yuan
Journal:  Int J Nurs Sci       Date:  2021-12-21

Review 7.  Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.

Authors:  Rebecca A Harrison; Noha Sharafeldin; Jennie L Rexer; Brennan Streck; Melissa Petersen; Ashley M Henneghan; Shelli R Kesler
Journal:  Oncologist       Date:  2021-07-12

8.  Physical activity, cardiorespiratory fitness, and cognitive function in postmenopausal women with breast cancer.

Authors:  Catherine M Bender; Susan M Sereika; Amanda L Gentry; Jennie E Duquette; Frances E Casillo; Anna Marsland; Adam M Brufsky; Steven Evans; Vikram C Gorantla; Tara L Grahovac; Priscilla F McAuliffe; Jennifer G Steiman; Yehui Zhu; Kirk I Erickson
Journal:  Support Care Cancer       Date:  2020-11-19       Impact factor: 3.359

9.  Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.

Authors:  Gabriella Martino; Antonino Catalano; Rita Maria Agostino; Federica Bellone; Nunziata Morabito; Carmen Giulia Lasco; Carmelo Mario Vicario; Peter Schwarz; Ulla Feldt-Rasmussen
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.